Orlistat is a gastrointestinal lipase inhibitor, and it reduces the absorption of dietary fat by about one-third
Possible Adjustments to Treatment Over Time As the patients health improves, their treatment plan may need adjustments
The genetic test reveals whether you carry variants associated with enhanced GLP-1 receptor sensitivity, appetite regulation responsiveness, or higher baseline metabolic rate
Side effects are similar to injectable tirzepatide and primarily affect the gastrointestinal system
We want to remind our patients that before the GLP-1 boom, there was a tried & true weight loss drug on the market, Phentermine, that has been in use for decades
These findings underscore the rapid transformation of obesity care for [teens and young adults] and highlight the need for evidence-based guidance on treatment sequencing and long-term outcomes, they wrote in the paper, published Monday in JAMA Pediatrics